Ansell purchases minority share of Yulex

NewsGuard 100/100 Score

Ansell Limited (ANN.AX), a global leader in protection solutions, today announced it has purchased a minority share of Yulex Corporation, a manufacturer of biopolymers derived from guayule.  The investment is not expected to have any material impact on Ansell's earnings per share in Fiscal Years 2012 and 2013.

Further, Ansell and Yulex executed an exclusive agreement for the global development, manufacturing and distribution rights for medical gloves, personal protective equipment gloves, and condoms made of guayule latex.

Guayule (Parthenium argentatum) is a commercial crop (a small evergreen shrub) and the only rubber-producing species other than the Brazilian rubber tree (Hevea brasiliensis) that has been used for latex production on a commercial scale.  Extensive scientific research suggests that guayule latex does not produce allergic reactions with natural rubber latex sensitive individuals.  

Magnus Nicolin, CEO of Ansell Limited commented, "Our agreements with Yulex are an important step in our strategy to accelerate the development of new innovative products while reducing our usage of rubber tree latex." 

"We are pleased to be partnering with Ansell," said Yulex Corporation CEO, Jeff Martin. "Our collaboration will advance the acceptance of guayule natural rubber as a U.S. biobased alternative for natural rubber and petroleum-based rubber products.   We are committed to developing 'green' renewable technologies for consumer and healthcare markets."

Source:

Yulex Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.